Advertisement China Ruitai sees fall in Q1 sales - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

China Ruitai sees fall in Q1 sales

China Ruitai, engaged in the production and sales of processed chemicals with a primary focus on non-ionic cellulose ether products for use in the production of pharmaceuticals, has reported sales of $9.59m for the first quarter ended 31 March 2011, a decrease of 6% , compared to $10.24m for the same period in 2010.

China Ruitai’s net income was $735,893, or $0.03 per diluted share, compared to net income of $1.94m, or $0.07 per diluted share, for the comparable period last year.

Income from operations was $1.55m, compared to $2.67m for the same period in 2010.

Gross profit decreased by 15% year-over-year to $2.8m.

China Ruitai chairman Dianmin Ma said along with others in the industry, their outlook for the balance of the year is positive despite some setbacks in the first quarter.